128 related articles for article (PubMed ID: 28599422)
1. A low serum Tat-interacting protein 30 level is a diagnostic and prognostic biomarker for hepatocellular carcinoma.
Fan SS; Liao CS; Cao YD; Xiao PL; Deng T; Luo RC; Duan HX
Oncol Lett; 2017 Jun; 13(6):4208-4214. PubMed ID: 28599422
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of changes in AFP, HTATIP2/TIP30, B7-H4 and inflammatory cytokines after transcatheter arterial chemoembolization.
Zhang P; Chen Z; Chen L; Zang H; Zhu B; Shao W; Niu W
J BUON; 2020; 25(2):1206-1211. PubMed ID: 32521927
[TBL] [Abstract][Full Text] [Related]
3. The effects of interventional therapy on serum HTATIP2/TIP30, B7-H4 and short-term curative effect in primary hepatocellular carcinoma.
Zheng ZJ; Fu J; Zhi F; Liu WJ; Guo YJ; Zhu DD; Mo JG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6778-6783. PubMed ID: 30402840
[TBL] [Abstract][Full Text] [Related]
4. High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker.
Kumtepe Y; Halici Z; Sengul O; Kunak CS; Bayir Y; Kilic N; Cadirci E; Pulur A; Bayraktutan Z
Eur J Med Res; 2013 Jun; 18(1):18. PubMed ID: 23800048
[TBL] [Abstract][Full Text] [Related]
5. The potential role of human HIV-1 TAT-Interactive Protein 2 levels in the pathogenesis of contact dermatitis.
Metin MS; Bilen H; Elmas ÖF; Akdeniz N
Turk J Med Sci; 2021 Dec; 51(6):3017-3021. PubMed ID: 34688245
[TBL] [Abstract][Full Text] [Related]
6. Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma.
Wei Z; Zhang Y; Lu H; Ying J; Zhao H; Cai J
Transl Cancer Res; 2022 Apr; 11(4):669-677. PubMed ID: 35571648
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.
Nörthen A; Asendorf T; Walson PD; Oellerich M
Clin Biochem; 2018 Feb; 52():20-25. PubMed ID: 29054441
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels.
She WH; Chan ACY; Cheung TT; Lo CM; Chok KSH
World J Hepatol; 2018 Feb; 10(2):308-318. PubMed ID: 29527266
[TBL] [Abstract][Full Text] [Related]
11. Plasma interleukin 17 in the diagnosis of hepatocellular carcinoma: a retrospective study of 39 cases.
Liu J; Zhou G; Lu W
J Cancer Res Ther; 2014 Dec; 10 Suppl():304-6. PubMed ID: 25693940
[TBL] [Abstract][Full Text] [Related]
12. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma.
Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE
J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712
[TBL] [Abstract][Full Text] [Related]
13. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
14. Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma.
Ao J; Chiba T; Kanzaki H; Kanayama K; Shibata S; Kurosugi A; Iwanaga T; Kan M; Sakuma T; Qiang N; Ma Y; Kojima R; Kusakabe Y; Nakamura M; Kobayashi K; Kiyono S; Kanogawa N; Saito T; Nakagawa R; Kondo T; Ogasawara S; Suzuki E; Nakamoto S; Muroyama R; Tawada A; Kato J; Kanda T; Maruyama H; Kato N
J Cancer; 2021; 12(9):2694-2701. PubMed ID: 33854629
[TBL] [Abstract][Full Text] [Related]
15. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
[TBL] [Abstract][Full Text] [Related]
16. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
El-Abd N; Fawzy A; Elbaz T; Hamdy S
Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
[TBL] [Abstract][Full Text] [Related]
20. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
